|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with IL-2Rβ x LAG3 x IL-2Rγ
100 Translational Medicine associated with IL-2Rβ x LAG3 x IL-2Rγ
0 Patents (Medical) associated with IL-2Rβ x LAG3 x IL-2Rγ